Key result
Clinically significant anxiety was independently associated with an increased risk of all-cause mortality (HR 1.547; 95% CI 1.006-2.380; P=0.047) in patients with MINOCA.
Why the study?
Anxiety symptoms are common and tied to poor prognosis in coronary artery disease, but their association with clinical outcomes in MINOCA is less clear.
Does anxiety increase the risk of all-cause mortality and MACE in patients with MINOCA?
Cohort (n=620)
No
Does anxiety increase the risk of all-cause mortality and MACE in patients with MINOCA?
Hazard Ratio: 1.547 (95% CI 1.006–2.38)
p-value: p=0.047
Anxiety is an independent prognostic factor for increased all-cause mortality and MACE in patients with MINOCA.
May inform risk stratification in MINOCA; leaves open whether anxiety treatment improves outcomes.
BACKGROUND: Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) accounts for approximately 5% - 6% of acute myocardial infarction (AMI) patients. Anxiety symptoms are common in patients with coronary artery disease (CAD), and are associated with a poor prognosis. However, the association between anxiety and MINOCA outcomes is less clear. HYPOTHESIS: Anxiety will be associated with clinical outcomes in patients with MINOCA. METHODS AND RESULTS: Between November 2014 and December 2016, 620 hospitalized patients with MINOCA were recruited from a single center. Within 7 days of coronary angiography, anxiety was assessed using the Zung Self-Rating Anxiety Scale. The primary endpoint was all-cause mortality; secondary endpoint was any major adverse cardiovascular event (MACE). After 3 years, 87 deaths and 151 MACE had occurred. Kaplan-Meier curves indicated the unadjusted rates of all-cause mortality (log-rank P = .045) and MACE (log-rank P = .023) were significantly higher in the anxiety group compared with the control group of patients without anxiety. Multivariate Cox regression analysis showed that clinically significant anxiety was an independent prognostic factor for all-cause mortality as well as MACE (hazard ratio [HR] = 1.547; 95% confidence interval [CI], 1.006-2.380; P = .047; HR = 1.460; 95% CI, 1.049-2.031; P = .025; respectively). CONCLUSIONS: Anxiety is significantly and independently associated with an increased risk of all-cause mortality and MACE in patients with MINOCA.
No takes yet. Share an insight, caveat, or question.
He et al. (2020) conducted a cohort in Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) (n=620). Clinically significant anxiety vs. Patients without anxiety was evaluated on All-cause mortality (HR 1.547, 95% CI 1.006-2.380, p=0.047). Clinically significant anxiety was independently associated with an increased risk of all-cause mortality (HR 1.547; 95% CI 1.006-2.380; P=0.047) in patients with MINOCA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: